Companies: 10,795·Total market cap: $144.5T
Castle Biosciences, Inc.

Castle Biosciences, Inc.

CSTLNASDAQHealthcare● Active
$20.29
$-0.72(-3.43%)
Market Cap$615394726
P/E Ratio
52W High$44.28
52W Low$14.59
Overview

Castle Biosciences, Inc.(CSTL)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CSTL · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.34B$0.33B$0.22B$0.14B$0.09B
Cost of Revenue$0.07B$0.06B$0.04B$0.03B$0.02B
Gross Profit$0.27B$0.27B$0.17B$0.11B$0.08B
Gross Margin %(computed)79.37%81.87%79.53%76.64%83.18%
Operating Expenses
R&D Expenses$0.05B$0.05B$0.05B$0.04B$0.03B
G&A Expenses$0.09B$0.08B$0.07B$0.06B$0.00B
Total Operating Expenses$0.32B$0.26B$0.24B$0.18B$0.12B
Operating Income($0.04B)$0.01B($0.07B)($0.07B)($0.04B)
Operating Margin %(computed)-12.44%2.61%-30.93%-53.16%-42.60%
Interest Income$0.01B$0.01B$0.01B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.03B)$0.02B($0.06B)($0.07B)($0.04B)
Income Tax Expense($0.01B)$0.00B$0.00B($0.00B)($0.01B)
Net Income($0.02B)$0.02B($0.06B)($0.07B)($0.03B)
Net Margin %(computed)-7.02%5.49%-26.15%-48.99%-33.26%
Per Share & EBITDA
EPS (Basic)$-0.83$0.66$-2.14$-2.58$-1.24
Wtd Avg Shares0.03B0.03B0.03B0.03B0.03B
EBITDA$0.01B$0.04B($0.05B)($0.06B)($0.04B)
EBITDA Margin %(computed)3.30%11.48%-20.49%-42.57%-38.91%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Castle Biosciences, Inc.

关于Castle Biosciences, Inc.(CSTL)损益表

Castle Biosciences, Inc.(CSTL)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CSTL实现营收$0.34B,毛利润$0.27B(毛利率79.37%),净利润($0.02B)(净利率-7.02%)。

常见问题

CSTL · 4 问

Castle Biosciences, Inc.(CSTL)2025财年营收为$0.34B,同比up3.7%。

CSTL revenueCSTL salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08